KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,094 | -39.5% | 1,805,346 | 0.0% | 1.08% | -16.3% |
| Q2 2023 | $41,505 | -22.4% | 1,805,346 | 0.0% | 1.29% | -59.5% |
| Q1 2023 | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
| Q4 2022 | $49,920 | -99.8% | 2,000,000 | +33.3% | 2.79% | +99.9% |
| Q3 2022 | $32,655,000 | +65.8% | 1,500,000 | +50.0% | 1.39% | +32.5% |
| Q2 2022 | $19,690,000 | -53.5% | 1,000,000 | 0.0% | 1.05% | -40.6% |
| Q1 2022 | $42,320,000 | -33.3% | 1,000,000 | 0.0% | 1.77% | +2.8% |
| Q4 2021 | $63,490,000 | +170.2% | 1,000,000 | +150.0% | 1.72% | +227.6% |
| Q3 2021 | $23,496,000 | +93.8% | 400,000 | +60.0% | 0.53% | +113.8% |
| Q2 2021 | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% |
| Q1 2021 | $9,715,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.3% |
| Q4 2020 | $15,500,000 | +91.9% | 250,000 | 0.0% | 0.33% | +69.9% |
| Q3 2020 | $8,078,000 | – | 250,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |